Dyne Therapeutics, Inc. Dividends, Common Stock
Dyne Therapeutics, Inc. (DYN) reported Dividends, Common Stock of $9.29 billion for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Shareholders' Equity
us-gaap:DividendsCommonStock · last filed 2022-11-03
- Dyne Therapeutics, Inc. dividends, common stock for the quarter ending 2022-09-30 was $180.29M, a 100.31% increase year-over-year.
- Dyne Therapeutics, Inc. dividends, common stock for the quarter ending 2022-06-30 was $120.47M, a 66.37% decline year-over-year.
- Dyne Therapeutics, Inc. dividends, common stock for the quarter ending 2022-03-31 was $8.99B, a 18.94% increase year-over-year.
- Dyne Therapeutics, Inc. dividends, common stock for the quarter ending 2021-09-30 was $90.01M.
| Period end | Dividends, Common Stock 3 month | Dividends, Common Stock 6 month | Dividends, Common Stock 9 month |
|---|---|---|---|
| 2022-09-30 | $180.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $300.76M derived: sum of 2 quarters · filed 2022-11-03 | $9.29B 10-Q · filed 2022-11-03 |
| 2022-06-30 | $120.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $9.11B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $8.99B 10-Q · filed 2022-05-02 | ||
| 2021-09-30 | $90.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $448.22M derived: sum of 2 quarters · filed 2022-11-03 | $8.01B 10-Q · filed 2022-11-03 |
| 2021-06-30 | $358.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $7.92B 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $7.56B 10-Q · filed 2022-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |